Myasthenia gravis: new therapeutic strategies.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009157:Myasthenia Gravis / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000906:Antibodies; D001323:Autoantibodies